Drug Screen 10 with Reflex Confirmation (AMP,BAR,BZO,COC,PCP,THC,OPI,OXY,MD,TRAM), Meconium
Use
Qualitative screening of meconium to detect in utero exposure to multiple drug classes, including amphetamines, barbiturates, benzodiazepines, cocaine, phencyclidine, cannabinoids, opiates (including tramadol), oxycodone, and methadone. Utilized in evaluating prenatal substance exposure for clinical and forensic purposes.
Special Instructions
Not provided.
Limitations
Presumptive positive immunoassay screenings require confirmation by LC‑MS/MS. Concentrations below specified cut-offs may not be detected. Highly contaminated samples or insufficient specimen may lead to rejection. Not intended for definitive quantitation without confirmation.
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
Result Turnaround Time
2-5 days
Related Documents
For more information, please review the documents below
Specimen
Tissue
Volume
1.0 g (analytical volume); preferred 5.0 g, minimum 1.0 g
Minimum Volume
1.0 g
Container
Sterile screw‑capped container
Collection Instructions
Collect meconium into or transfer from diaper into sterile screw‑capped container; pool multiple collections permitted; diapers not accepted
Causes for Rejection
Specimens from diapers (not accepted); heavily contaminated with stool
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | < 3 d |
| Refrigerated | 2 w |
| Frozen | 6 m |
Other tests from different labs that may be relevant